David Delgrange

543 total citations
7 papers, 454 citations indexed

About

David Delgrange is a scholar working on Hepatology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David Delgrange has authored 7 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 6 papers in Epidemiology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David Delgrange's work include Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). David Delgrange is often cited by papers focused on Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). David Delgrange collaborates with scholars based in France, Japan and Belgium. David Delgrange's co-authors include Czeslaw Wychowski, Jean Dubuisson, Takaji Wakita, Yves Rouillé, André Pillez, Laurence Cocquerel, François Helle, Gilles Duverlie, Sandrine Castelain and Geert Maertens and has published in prestigious journals such as PLoS ONE, Journal of Virology and Journal of General Virology.

In The Last Decade

David Delgrange

7 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Delgrange France 6 363 267 106 100 43 7 454
Jianwen He China 5 315 0.9× 227 0.9× 144 1.4× 37 0.4× 37 0.9× 7 437
Kathrin Hueging Germany 10 398 1.1× 318 1.2× 80 0.8× 68 0.7× 38 0.9× 10 511
Sylvie Trassard France 6 295 0.8× 295 1.1× 87 0.8× 60 0.6× 21 0.5× 6 405
M Sidorkiewicz Poland 10 217 0.6× 154 0.6× 93 0.9× 41 0.4× 50 1.2× 29 337
Mainak Majumder United States 11 431 1.2× 353 1.3× 191 1.8× 39 0.4× 127 3.0× 15 676
Thomas F. Baumert France 10 511 1.4× 454 1.7× 94 0.9× 85 0.8× 117 2.7× 12 706
Sonia Molina France 6 356 1.0× 305 1.1× 54 0.5× 56 0.6× 36 0.8× 12 444
S. H. Yap Belgium 11 353 1.0× 359 1.3× 76 0.7× 23 0.2× 36 0.8× 19 475
Darren Hockman Canada 16 333 0.9× 274 1.0× 311 2.9× 170 1.7× 74 1.7× 18 693
Noha G. Bader El Din Egypt 15 364 1.0× 350 1.3× 167 1.6× 62 0.6× 81 1.9× 47 614

Countries citing papers authored by David Delgrange

Since Specialization
Citations

This map shows the geographic impact of David Delgrange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Delgrange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Delgrange more than expected).

Fields of papers citing papers by David Delgrange

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Delgrange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Delgrange. The network helps show where David Delgrange may publish in the future.

Co-authorship network of co-authors of David Delgrange

This figure shows the co-authorship network connecting the top 25 collaborators of David Delgrange. A scholar is included among the top collaborators of David Delgrange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Delgrange. David Delgrange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Rocha‐Perugini, Vera, Muriel Lavie, David Delgrange, et al.. (2009). The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry. BMC Microbiology. 9(1). 111–111. 28 indexed citations
2.
Rocha‐Perugini, Vera, David Delgrange, Czeslaw Wychowski, et al.. (2008). The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry. PLoS ONE. 3(4). e1866–e1866. 85 indexed citations
3.
Chevalier, Christophe, Aure Saulnier, Yann Bénureau, et al.. (2007). Inhibition of Hepatitis C Virus Infection in Cell Culture by Small Interfering RNAs. Molecular Therapy. 15(8). 1452–1462. 41 indexed citations
4.
Delgrange, David, André Pillez, Sandrine Castelain, et al.. (2007). Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. Journal of General Virology. 88(9). 2495–2503. 125 indexed citations
5.
Rouillé, Yves, François Helle, David Delgrange, et al.. (2006). O.174 Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. Journal of Clinical Virology. 36. S53–S54. 2 indexed citations
6.
Breiman, Adrien, Damien Vitour, Myriam Vilasco, et al.. (2006). A hepatitis C virus (HCV) NS3/4A protease-dependent strategy for the identification and purification of HCV-infected cells. Journal of General Virology. 87(12). 3587–3598. 8 indexed citations
7.
Rouillé, Yves, François Helle, David Delgrange, et al.. (2006). Subcellular Localization of Hepatitis C Virus Structural Proteins in a Cell Culture System That Efficiently Replicates the Virus. Journal of Virology. 80(6). 2832–2841. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026